Objective To investigate whether preparations containing Wallal and/or Warr
ego viruses could cause disease when inoculated subcutaneously into captive
kangaroos.
Design and procedure Four groups of two kangaroos, seronegative to both Wal
lal and Warrego virus, were each inoculated with wild Wallal virus, culture
d Wallal virus, wild Warrego virus, or wild Warrego virus followed by wild
Wallal virus after 3 weeks. A single uninoculated animal served as a contro
l. Animals were monitored weekly under anaesthesia, examined ophthalmoscopi
cally (including fundic photography), and samples collected for haematologi
cal and serum biochemical analysis, virus isolation, PCR and serological ex
amination for antibodies against Wallal and Warrego viruses. Animals inocul
ated with cultured Wallal virus were killed at week 10, and remaining kanga
roos were reinoculated with cultured Wallal virus at week 12.
Results Virus was isolated from the blood of two kangaroos 2 weeks after in
oculation with Wallal virus preparations, and from a third kangaroo 2 weeks
after reinoculation. By 3 weeks after inoculation, all kangaroos given Wal
lal virus preparations had seroconverted to Wallal virus and one had seroco
nverted to Warrego virus. Fundic changes were detected in the three viraemi
c kangaroos 4 or more weeks after inoculation, and lesions were present in
the eye and brain typical of those seen in field cases of chorioretinitis.
No other kangaroos had lesions. Wallal virus was identified by PCR and immu
nohistochemical analysis in the retina of one affected animal and orbivirus
-like particles were seen by electron microscopy in the remains of retinal
cells.
Conclusion The condition of chorioretinitis was reproduced in three of eigh
t kangaroos by inoculation with preparations containing Wallal virus.